We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Treatment for Peripheral Vascular Disease

By HospiMedica staff writers
Posted on 15 Jun 2004
A new treatment for patients with blocked blood vessels in their legs employs a device that removes plaque altogether, unlike methods that merely stretch the artery and push plaque up against artery walls. More...
The device has been cleared by the U.S. Food and Drug Administration (FDA).

Called the SilverHawk Plaque Excision System, the device uses a tiny rotating blade to shave plaque from artery walls. The device acts somewhat like a lawnmower, first cutting the plaque and then, like a trash compactor, compressing the plaque into the nose cone of the device, which is then removed. The SilverHawk system was developed by Fox Hollow Technologies, Inc. (Redwood City, CA, USA).

Blockages in the legs are a challenge for doctors because plaque tends to build up along the entire length of the artery. This makes it difficult to use stents or angioplasty because they generally target a small section of the artery. Even when stents or angioplasty is used, the arteries tend to re-narrow over time. The most common symptom of peripheral vascular disease (PVD) is leg pain. The earlier PVD is detected, the easier the treatment.

"This is a serious, often overlooked disease,” said Dr. Daniel Dulas, a cardiologist with Mercy & Unity Hospitals in Coon Rapids (MN, USA). "Some patients with peripheral vascular disease can't walk more than a few steps because of the pain in their legs. Even worse, some face life-changing alternatives such as amputation.”




Related Links:
Fox Hollow Technologies

Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Electric Bed
DIXION Intensive Care Bed
Syringes
Prefilled Saline Flush Syringes
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.